Finance

Lists
VERA:NASDAQ
Vera Therapeutics, Inc
29,88 $
+0,50%
(+0,15) 1D
29,88 $
0,00% (0,00)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
29,57 $
High
30,51 $
Low
29,46 $
Mkt. cap
2,15 մլրդ
Avg. vol.
2,39 մլն
Volume
525,97 հզր
52-wk high
56,04 $
52-wk low
23,05 $
EPS
-5,86 $
Beta
1,06
Shares outstanding
72,06 մլն
No. of employees
361
Open
29,57 $
High
30,51 $
Low
29,46 $
Mkt. cap
2,15 մլրդ
Avg. vol.
2,39 մլն
Volume
525,97 հզր
52-wk high
56,04 $
52-wk low
23,05 $
EPS
-5,86 $
Beta
1,06
Shares outstanding
72,06 մլն
No. of employees
361
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees361
Founded2016
HeadquartersBrisbane, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteveratx.com
Analyst ratings
Based on 11 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current 29,88 $
100,00 $ (+234,67%)
Average
73,00 $ (+144,31%)
Lowest
34,00 $ (+13,79%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Buy
Maintained
60,00 $
+100,8%
10/09/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
90,00 $
+201,2%
10/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
59,00 $
+97,5%
09/16/2026
Laura Chico
Wedbush
Hold
Maintained
34,00 $
+13,8%
09/16/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
70,00 $
+134,3%
09/15/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
90,00 $
+201,2%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
78,00 $
+161%
08/31/2026
Vamil Divan
Guggenheim
Buy
Reiterated
76,00 $
+154,4%
08/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
100,00 $
+234,7%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
91,00 $
+204,6%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
70,00 $
+134,3%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 $
+201,2%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
88,00 $
+194,5%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
35,00 $
+17,1%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
56,47 մլն
59,31 մլն
86,01 մլն
60,08 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,46 մլն
34,90 մլն
39,12 մլն
52,41 մլն
Operating expense
83,93 մլն
94,21 մլն
125,13 մլն
112,49 մլն
Total operating expenses
83,93 մլն
94,21 մլն
125,13 մլն
112,49 մլն
Operating income
-83,93 մլն
-94,21 մլն
-125,13 մլն
-112,49 մլն
Other non operating income
-137,00 հզր
-303,00 հզր
-32,00 հզր
-483,00 հզր
EBT including unusual items
-80,29 մլն
-91,10 մլն
-121,03 մլն
-109,47 մլն
EBT excluding unusual items
-80,29 մլն
-90,90 մլն
-120,63 մլն
-109,47 մլն
Income tax expense
-
1,00 հզր
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-80,29 մլն
-91,10 մլն
-121,03 մլն
-109,47 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,26
-1,39
-1,69
-1,52
Interest and investment income
5,74 մլն
5,52 մլն
6,36 մլն
5,35 մլն
Interest expense
-1,96 մլն
-1,90 մլն
-1,82 մլն
-1,85 մլն
Net interest expenses
3,78 մլն
3,61 մլն
4,53 մլն
3,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-83,80 մլն
-94,07 մլն
-124,99 մլն
-112,36 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps